NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company ("Chemours" or the "Company") (NYSE:CC). Such investors are advised ...
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of WisdomTree, Inc. ("WisdomTree" or the "Company") (NYSE:WT). Such investors are advised ...
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Warner Bros. Discovery, Inc. ("WBD" or the "Company") (NASDAQ:WBD). Such investors are ...
14h
On September 4, 2024, C3.ai issued a press release announcing its financial results for fiscal first quarter 2025. Among other items, C3.ai issued second-quarter sales guidance in the range of $88.6 ...
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of AvidXchange Holdings, Inc. ("AvidXchange" or the "Company") (NASDAQ:AVDX). Such ...
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Ibotta, Inc. ("Ibotta" or the "Company") (NYSE:IBTA). Such investors are advised to ...
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Metagenomi, Inc. ("Metagenomi" or the "Company") (NASDAQ:MGX). Such investors are ...
On August 7, 2024, Cardlytics announced its second quarter 2024 financial results, revealing a 9% year-over-year decrease in revenue to $69.6 million, alongside a 3% decline in adjusted contribution ...
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Piedmont Lithium Inc. ("Piedmont Lithium" or the "Company") (NASDAQ:PLL). Such investors ...
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Mineralys Therapeutics, Inc. ("Mineralys" or the "Company") (NASDAQ:MLYS). Such ...
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Globus Medical, Inc. ("Globus" or the "Company") (NYSE:GMED). Such investors are advised ...
NEW YORK, NY / ACCESSWIRE / September 5, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. ("Enfusion" or the "Company") (NYSE:ENFN). Such investors are advised to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback